Holen Sie sich die Stockscreener-App
1.055
1.44%
0.015
Handel nachbörslich:
1.07
0.015
+1.42%
Schlusskurs vom Vortag:
$1.04
Offen:
$1.04
24-Stunden-Volumen:
59,938
Relative Volume:
0.61
Marktkapitalisierung:
$36.32M
Einnahmen:
-
Nettoeinkommen (Verlust:
-
KGV:
-11.96
EPS:
-0.0882
Netto-Cashflow:
-
1W Leistung:
-2.23%
1M Leistung:
-7.46%
6M Leistung:
-36.06%
1J Leistung:
-87.94%
1-Tages-Spanne:
$0.9801
$1.08
1-Wochen-Bereich:
$0.9147
$1.1018
52-Wochen-Spanne:
$0.51
$9.35
Jupiter Neurosciences Inc Stock (JUNS) Company Profile
Firmenname
Jupiter Neurosciences Inc
Sektor
Branche
Telefon
(561) 406-6154
Adresse
1001 NORTH US HWY 1, JUPITER
Vergleichen Sie JUNS mit anderen Aktien
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
JUNS
Jupiter Neurosciences Inc
|
1.055 | 35.80M | 0 | 0 | 0 | -0.0882 |
|
VRTX
Vertex Pharmaceuticals Inc
|
468.38 | 113.87B | 11.74B | 3.68B | 3.34B | 14.19 |
|
REGN
Regeneron Pharmaceuticals Inc
|
776.54 | 80.22B | 14.25B | 4.58B | 3.88B | 41.77 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
406.40 | 52.56B | 3.21B | 43.57M | 221.36M | 0.2405 |
|
ARGX
Argen X Se Adr
|
803.74 | 49.31B | 3.06B | 1.28B | 447.35M | 19.67 |
|
INSM
Insmed Inc
|
175.07 | 37.37B | 447.02M | -1.18B | -906.14M | -6.1812 |
Jupiter Neurosciences Inc Aktie (JUNS) Neueste Nachrichten
Jupiter Neurosciences expands equity financing through SEPA advances - MSN
What margin trends mean for Jupiter Neurosciences Inc. stockInflation Impact on Stocks & Small Investment Big Gains - bollywoodhelpline.com
Jupiter Neurosciences Expands Equity Financing Through SEPA Advances - TipRanks
Jupiter Neurosciences Signs Multiple Material Agreements - TradingView — Track All Markets
Join Jupiter Neurosciences’ Exclusive Live Investor Webinar and Q&A Session on January 6 - marketscreener.com
The best and worst-performing stocks of 2025 | 2025-12-22 | Investing News - Stockhouse
Jupiter Neurosciences Shareholders Approve Key Governance Measures - TipRanks
The best and worst-performing stocks of 2025 - MSN
New Highs: What margin trends mean for Jupiter Neurosciences Inc. stockJuly 2025 Gainers & Community Verified Trade Signals - moha.gov.vn
Stock Analysis: What margin trends mean for Jupiter Neurosciences Inc. stockMarket Sentiment Review & AI Enhanced Market Trend Forecasts - Улправда
Will Jupiter Neurosciences Inc. stock sustain high P E ratiosEarnings Performance Report & Technical Pattern Based Signals - Улправда
Will Jupiter Neurosciences Inc. stock benefit from AI adoptionStop Loss & Daily Growth Stock Investment Tips - DonanımHaber
Can Jupiter Neurosciences Inc. stock maintain growth trajectoryMarket Sentiment Review & Low Risk High Win Rate Picks - Улправда
Why Jupiter Neurosciences Inc. stock remains on buy listsQuarterly Trade Review & Stepwise Trade Execution Plans - Улправда
Fed Meeting: Can Jupiter Neurosciences Inc. stock maintain growth trajectoryJuly 2025 Rallies & Reliable Entry Point Trade Alerts - Улправда
Will Jupiter Neurosciences Inc. stock split again soon2025 Trade Ideas & Weekly Consistent Profit Watchlists - Улправда
Jupiter Neurosciences Achieves Regulatory and Commercial Milestones in First Year as Public Company - citybuzz -
From FDA Clearance To The Launch Of A Consumer Line, Jupiter Neurosciences Hit Milestones In 2025; More On The Horizon | Corporate - EQS News
From FDA Clearance To The Launch Of A Consumer Line, Jupiter Neurosciences Hit Milestones In 2025; More On The Horizon - NewMediaWire
$50B+ Longevity Opportunity: Jupiter Neurosciences CEO Christer Rosen & President Alison Silva, Live at Nasdaq - Yahoo Finance
Jupiter Neurosciences Marks Transformational First Year as - GlobeNewswire
Why Jupiter Neurosciences Inc. stock attracts global investorsWeekly Profit Summary & Daily Chart Pattern Signals - Newser
Jupiter Neurosciences Marks Transformational First Year as a Public Company, Entering 2026 with Powerful Clinical and Commercial Momentum - Yahoo Finance
Jupiter Neurosciences (NASDAQ: JUNS) to Join NobleCon21 Emerging Growth Equity Conference - Stock Titan
Published on: 2025-11-27 23:20:01 - moha.gov.vn
Jupiter Neurosciences files rospectus related to resale of up to 10 million shares of our common stock by selling stockholder - marketscreener.com
Jupiter Neurosciences Inc Stock Analysis and ForecastPortfolio Diversification Tips & Watch Expert Picks Before They Rally - earlytimes.in
How Jupiter Neurosciences Inc. stock reacts to global recession fearsTrade Analysis Report & Expert Verified Stock Movement Alerts - newser.com
Will Jupiter Neurosciences Inc. stock deliver shareholder valueJuly 2025 Market Mood & Low Risk Investment Opportunities - newser.com
How Jupiter Neurosciences Inc. stock benefits from strong dollar2025 Pullback Review & Pattern Based Trade Signal System - newser.com
Is Jupiter Neurosciences Inc. stock overvalued by current metricsIndex Update & Weekly Breakout Stock Alerts - newser.com
A activity2025 Key Highlights & High Accuracy Buy Signal Tips - newser.com
Why hedge funds are buying Jupiter Neurosciences Inc. stockGlobal Markets & Free Reliable Trade Execution Plans - newser.com
Is Jupiter Neurosciences Inc. stock safe for conservative investorsProfit Target & Consistent Return Investment Signals - newser.com
Will Jupiter Neurosciences Inc. stock continue dividend increasesJuly 2025 Sector Moves & Risk Managed Trade Strategies - newser.com
Finanzdaten der Jupiter Neurosciences Inc-Aktie (JUNS)
Umsatz
Nettogewinn
Free Cashflow
ENV
2.52%
0.07%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):